MALARONE (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the MALARONE drug offered from GlaxoSmithKline LLC. This Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | atovaquone and proguanil hydrochloride |
SUBSTANCE NAME: | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2000-07-26 |
END MARKETING DATE: | 0000-00-00 |
MALARONE HUMAN PRESCRIPTION DRUG Details:
Item Description | MALARONE from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250; 100(mg/1; mg/1) |
START MARKETING DATE: | 2000-07-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0675_a7e07c5d-13b1-4279-a33c-fc07bb36bad4 |
PRODUCT NDC: | 0173-0675 |
APPLICATION NUMBER: | NDA021078 |
Other ATOVAQUONE; PROGUANIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: